🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
AMBRE is a phase III study comparing two standard treatments as initial met...
Status
Active Not Recruiting
Location
Centre Hospitalier Lyon Sud
Start Date
2020-06-11
Trial ID
NCT04158362
The main purpose of this study is to learn more about the safety and tolera...
Status
Completed
Location
MNJ Institute of Oncology
Start Date
2021-02-22
Trial ID
NCT04707196
Treatments Being Tested
Given the uncertain benefit in efficacy of adding CDK 4/6 to first rather t...
Status
Active Not Recruiting
Location
Jeroen Bosch Ziekenhuis
Start Date
2017-11-09
Trial ID
NCT03425838
Treatments Being Tested
This was a randomized, double-blind, placebo-controlled study conducted in ...
Status
Completed
Location
Novartis Investigative Site
Start Date
2018-08-29
Trial ID
NCT03671330
Treatments Being Tested
To compare the combination of Ribociclib plus goserelin acetate with hormon...
Status
Completed
Location
Novartis Investigative Site
Start Date
2019-02-25
Trial ID
NCT03839823
The reason for this study is to see if the drug abemaciclib in combination ...
Status
Withdrawn
Location
Southern Cancer Center, P.C.
Start Date
2019-09-16
Trial ID
NCT03988114
Treatments Being Tested
The purpose of this study is to determine whether exemestane plus dasatinib...
Status
Completed
Location
Compassionate Cancer Care Medical Group, Inc
Start Date
2009-02
Trial ID
NCT00767520
Treatments Being Tested
Although randomized controlled trials (RCTs) provide evidence of efficacy, ...
Status
Completed
Location
Novartis Investigative Site
Start Date
2016-03-15
Trial ID
NCT02753686
The purpose of this study was to determine whether treatment with tamoxifen...
Status
Completed
Location
Comprehensive Blood and Cancer SC-2
Start Date
2014-11-20
Trial ID
NCT02278120
Treatments Being Tested
The CLARA trial is a phase II window-of-opportunity trial evaluating how a ...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-08-01
Trial ID
NCT07676331
Treatments Being Tested